This document discusses classifying cancer gene expression data using machine learning algorithms. It references 7 papers on topics like using distributed support vector machines on genomics data, leukemia sub-classification with committee neural networks, and cancer classification with microarray and few gene expressions. The objective is to classify acute myeloid leukemia and acute lymphoblastic leukemia patients using machine learning.
This document discusses classifying cancer gene expression data using machine learning algorithms. It references 7 papers on topics like using distributed support vector machines on genomics data, leukemia sub-classification with committee neural networks, and cancer classification with microarray and few gene expressions. The objective is to classify acute myeloid leukemia and acute lymphoblastic leukemia patients using machine learning.
This document discusses classifying cancer gene expression data using machine learning algorithms. It references 7 papers on topics like using distributed support vector machines on genomics data, leukemia sub-classification with committee neural networks, and cancer classification with microarray and few gene expressions. The objective is to classify acute myeloid leukemia and acute lymphoblastic leukemia patients using machine learning.
Topic: Gene Expression Data Classification of Cancer using
Machine learning Algorithm
Research paper reference:
1. Fast Training on Large Genomics Data using Distributed Support Vector Machines. 2. Gene Expression Based Leukemia Sub-Classification Using Committee Neural Networks. 3. Cancer Classification Based on Micro array Gene Expression Data Using Deep Learning. 4. Accurate Cancer Classification Using Expressions of Very Few Genes. 5. Cancer Classification from Gene Expression Data by NPPC Ensemble. 6. A comparative study of different machine learning methods on micro array gene expression data. 7. Gene Expression Data Classification Using Consensus Independent Component Analysis.
Objective: 1. The objective is to classify patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) using Machine Learning Algorithm.